Pre-mixed amino acid and dextrose solutions usedfor parenteral nutrition had additions made to them at a ward level by medical officers. Samples of the solutions of the study group and a control group were taken at six hours and at the end of the infusion time and were analysed microbiologically for growth of microorganisms. No organism was isolated from either group. We conclude that making additions to pre-mixed amino acid/dextrose solutions at the ward level does not constitute a microbiological hazard for the patient.
The preparation of parenteral nutntlOn (PN) fluids and their manipulations are advised to be carried out by a pharmacist in a laminar flow hood using an aseptic technique. l . 3 This practice can decrease the risk of extrinsic contamination. 4 To facilitate this practice the Australian Society for Parenteral and Enteral Nutrition has issued extensive guidelines. 5 Other authors have clearly shown that the growth of micro-organisms in some PN solutions is retarded or even inhibited. 6 . 9 It is known that lipid solutions support the growth of micro-organisms to a greater extent than solutions containing a synthetic amino acid and dextrose mixture. ll ,12 In a previous report, Bronsen et at. demonstrated absence of microbial growth in total parenteral solutions prepared by patients at home on a home PN programme. 13 What has not been clearly shown is that manipulation of PN solutions in a ward environment is a microbiological hazard to the patient. We undertook this study to establish that manipulation of parenteral nutrition solutions at ward level is not microbiologically hazardous to patients receiving PN.
MATERIALS AND METHODS
Parenteral Nutrition (PN) is administered by staff of the Intensive Care Unit to patients considered suitable and when clinically indicated.
The solutions used in this study were a pre-mixed solution of 10% amino acids and dextrose solution containing electrolytes (Synthamin 17 + 50% Dextrose -Baxter HeaIthcare Pty. Ltd.) and a lipid solution (Intralipid 20%). These are administered to the patients to provide between 2000 and 3000 kilocalories per day. The lipid solution is given separately on a daily or second daily basis depending on the requirements of the patient. Extra additions to this regimen are often needed to fulfil normal daily requirements and to replace known deficiencies and ongoing losses. The most commonly added substances are trace elements, vitamins, calcium chloride and potassium chloride.
Not all bags of parenteral nutrition solution require additions to be made to them.
In this study the additions were made by the junior medical staff using an aseptic technique. Masks were worn and after scrubbing their hands the staff wore sterile gloves and gowns. The injection ports of the bags were sterilised with isopropyl alcohol prior to injection of the required additives to the one-litre bags of solution via the rubber bung. The number of additions varied from one to five. The bags were then administered to the patients at the pre-determined rate. The bags were not stored f~r any period of time.
Two samples were taken for microbiological examination. One sample of 20 ml was taken after six hours and the last 50 ml of the solution constituted the second sample. PN solutions which did not require additions to them acted as controls.
Samples excluded from analysis were those that were too small, those which had leaked during transport to the laboratory or those samples which had failed to be reserved. The samples were analysed for sterility by the use of membrane filtration as an alternative to the direct inoculation of culture media as previously suggested 14 and employed. IS In the microbiological laboratory the samples were aseptically divided into 10 ml aliquots (sixhour samples) or 25 ml aliquots (terminal samples). The samples were individually passed through 47 mm diameter membrane filters of pore size 0.45 microns (Sartorius SM 13806) under vacuum. The filter was rinsed by passing 100 ml of sterile distilled water through the filter under vacuum.
Pre-sterilised 47 mm absorbent media pads in petri dishes were reconstituted with 3.0 ml sterile distilled water. The re-constituted pads (Sartorius SM 14055) contain nutrient broth with tetrazolium chloride for easy visualisation of bacterial colonies. Filters were aseptically placed onto the surface of the re-constituted pads.
The duplicate filters were incubated at 37°C and 30°C and were examined for growth after 72 hours of aerobic incubation. They were not tested for anaerobic pathogens.
RESULTS
Fifteen patients were included in the trial and provided 356 samples from 246 bags of solution .. 224 samples came from the study group which had the additions made to the PN solution and 132 from the control group which had no additions made to the solution. These were further divided into six-hourly and terminal samples as seen in Figure 1 .
The 224 samples in the study group did not grow any organisms on culture nor did the 132 samples in the control group.
The 95% confidence intervals for the probability of a positive culture are: 0.0, 0.026 for the study sample after six hours. 0.0, 0.039 for the control sample after six hours. None of the patients had PN ceased because of suspected or proven sepsis secondary to the administration of PN.
DISCUSSION
Parenteral nutrition has an important role to play in the management of very ill patients, who for many reasons cannot be fed enterally. It plays a supportive role in the management of specific disease processes and is indicated in patients with prolonged gastrointestinal tract failure or in those who have acutely lost 10 to 15% of their body weight. 16 Although theoretically beneficial for many disease processes, clinical trials have not consistently shown a dramatic clinical effect of PN support. With the exception of the inadequate bowel syndrome, it is difficult to justify its use to prevent or replenish mild to moderate malnutrition in clinical practice. I? Improved nutritional status cannot be equated with improved clinical outcome. However, it is improper to withhold PN support in the light of overwhelming anecdotal evidence as to its value in many disease states.
The compounding and preparation of solutions for PN have to a large extent been confined to large hospitals with the pharmacy expertise and staffing to comply with the recommendations. This may lead to inflexibility in the administration ofPN and the potential for more widespread contamination of fluids if the procedure becomes faulty. 18 Now that the large pharmaceutical companies will carry out the bulk of the compounding in large industrial centres, it is appropriate that the preparation of the final additions at the consumer end of the chain be kept simple and flexible. This study has gone some way towards this goal. It has shown that the making of additions to PN solutions at the ward level is not associated with a measurable increase in contamination. There was no detectable increase in hazard to the patients either microbiologically or clinically. What is not shown by the study is the chemical incompatibility, if any, which may occur by making additions to PN solutions. Having shown that it is microbiologically safe to make these additions, it is within the capacity of the manufacturer of the solutions to provide the clinicians with clear guidelines to avoid chemical incompatibilities. If this can be achieved, the demystification of PN can continue .
All possible samples were not subjected to culture because they were either not collected or leaked in transit to the laboratory. It is theoretically possible that one of these samples could have been Anaesthesia and Intensive Care, Vol. 18, No. 4, November, 1990 contaminated. However, the omission and leakage of samples was not controlled and is assumed to have occurred in an unbiased fashion. These is no reason to doubt that they would not have given similar results to those obtained from samples in the study.
It is widely accepted that the greatest risk of infection associated with PN is via catheter sepsis. 1, 4 When additives are made to PN solutions using a technique such as ours, the lack of evidence of extrinsic contamination of the PN solutions in this study would tend to support this, A further study is now indicated to show that making additions to PN solutions should be approached in a similar manner to that of making additions to any other intravenous solution at the ward leveL That is, to use a clean, careful technique, Such a study would allow PN solutions to be treated in a similar fashion to any other solution, thus simplifying the administration ofPN and making this form of support more easily available outside major centres.
